NeoGenomics, Inc. Debt Securities Available For Sale Excluding Accrued Interest Current
NeoGenomics, Inc. (NEO) had Debt Securities Available For Sale Excluding Accrued Interest Current of $0 as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent · last filed 2026-07-28
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest Current $0.00.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest Current $0.00.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest Current $0.00.
- 2025-06-30: Debt Securities Available For Sale Excluding Accrued Interest Current $8.96M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-28 |
| 2025-12-31 | $0.00 10-Q · filed 2026-07-28 |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-28 |
| 2025-06-30 | $8.96M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $11.89M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $19.83M 10-K · filed 2026-02-17 |
| 2024-09-30 | $25.82M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $32.77M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $52.92M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $72.72M 10-K · filed 2025-02-18 |
| 2023-09-30 | $96.03M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $120.27M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $142.31M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $174.81M 10-K · filed 2024-02-20 |
| 2022-09-30 | $177.41M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $182.32M 10-Q · filed 2022-08-09 |
| 2021-12-31 | $198.56M 10-K · filed 2023-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |